Skip to main content
Thor Medical ASA logo

Thor Medical ASA — Investor Relations & Filings

Ticker · NANOV ISIN · NO0010597883 LEI · 5967007LIEEXZXG6DK30 OL Manufacturing
Filings indexed 106 across all filing types
Latest filing 2023-03-23 Annual Report
Country NO Norway
Listing OL NANOV

About Thor Medical ASA

https://www.thormedical.com/

Thor Medical ASA is a producer and supplier of alpha-particle emitters for cancer therapy. The company specializes in manufacturing isotopes, such as Thorium-228, by separating decay products from naturally occurring Thorium-232. This is achieved through a proprietary production technology that offers high efficiency, cost-competitiveness, and superior environmental friendliness. The company provides these critical alpha-emitters to partners developing next-generation targeted alpha therapies for precision oncology.

Recent filings

Filing Released Lang Actions
Annual Report 2022
Annual Report Classification · 100% confidence The document explicitly starts with the title "# Annual Report 2022". The table of contents further confirms this by listing sections typical of an annual report, such as 'Corporate Overview', 'Governance', 'Board of directors' report', 'Financial statements' (including consolidated statements of profit or loss, financial position, and cash flows), 'General accounting policies', and 'Auditor's report'. The document length is substantial (over 300,000 characters), indicating a comprehensive filing rather than a brief announcement. This content structure and title directly map to the definition of an Annual Report. FY 2022
2023-03-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.